FDA Inspection 1309034 — Keck Medical Center Of USC (USC Kenneth Norris Cancer Hospital)
The FDA completed an inspection of Keck Medical Center Of USC (USC Kenneth Norris Cancer Hospital) on Mar 11, 2026 in Los Angeles, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 11, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Los Angeles, CA (United States)